Differentiation of human amniotic fluid-derived mesenchymal stem cells into type II alveolar epithelial cells in vitro

International Journal of Molecular Medicine

Volumn 33, Issue 6, 2014, Pages 1507-1513

  Li, Yaqing ^a   Xu, Wulin ^a   Yan, Jianping ^a   Xia, Yingjie ^a   Gu, Chao ^a   Ma, Yingyu ^a   Tao, Houquan ^a  

^a ZHEJIANG PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Alveolar epithelial cells; Amniotic fluid; Chronic obstructive pulmonary disease; Mesenchymal stem cells

Indexed keywords

5' NUCLEOTIDASE; ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; ACTIVIN A; BETA1 INTEGRIN; CD14 ANTIGEN; CD19 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; ENDOGLIN; HERMES ANTIGEN; MESSENGER RNA; OCTAMER TRANSCRIPTION FACTOR 4; SURFACTANT PROTEIN A; SURFACTANT PROTEIN C; THY 1 ANTIGEN;

AMNION FLUID; AMNIOTIC FLUID DERIVED MESENCHYMAL STEM CELL; ARTICLE; CELL DIFFERENTIATION; CELL ISOLATION; CONTROLLED STUDY; EMBRYO; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; LAMELLAR BODY; LUNG ALVEOLUS EPITHELIUM; MESENCHYMAL STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGENERATIVE MEDICINE; SAMPLING; CELL CULTURE; CYTOLOGY; EPITHELIUM CELL; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; MESENCHYMAL STROMA CELL; METABOLISM; PHYSIOLOGY; PREGNANCY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

AMNIOTIC FLUID; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELLS, CULTURED; EPITHELIAL CELLS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MESENCHYMAL STROMAL CELLS; PREGNANCY; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; PULMONARY SURFACTANT-ASSOCIATED PROTEIN C; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84899575921     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2014.1705     Document Type: Article

References (33)

1. Whitsett JA, Wert SE and Weaver TE: Alveolar surfactant homeostasis and the pathogenesis of pulmonary disease. Annu Rev Med 61: 105-119, 2010.
2. Hoffman AM and Ingenito EP: Alveolar epithelial stem and progenitor cells: emerging evidence for their role in lung regeneration. Curr Med Chem 19: 6003-6008, 2012.
3. Tsuji T, Aoshiba K and Nagai A: Alveolar cell senescence exacerbates pulmonary inflammation in patients with chronic obstructive pulmonary disease. Respiration 80: 59-70, 2010.
4. Miyake Y, Kaise H, Isono K, Koseki H, Kohno K and Tanaka M: Protective role of macrophages in noninflammatory lung injury caused by selective ablation of alveolar epithelial type II Cells. J Immunol 178: 5001-5009, 2007. (Pubitemid 46595283)
5. Corti M, Brody AR and Harrison JH: Isolation and primary culture of murine alveolar type II cells. Am J Respir Cell Mol Biol 14: 309-315, 1996. (Pubitemid 126440495)
6. Ehrhardt C, Kim KJ and Lehr CM: Isolation and culture of human alveolar epithelial cells. Methods Mol Med 107: 207-216, 2005.
7. Fujino N, Kubo H, Suzuki T, et al: Isolation of alveolar epithelial type II progenitor cells from adult human lungs. Lab Invest 91: 363-378, 2011.
8. Gaur M, Ritner C, Sievers R, Pedersen A, Prasad M, Bernstein HS and Yeqhiazarians Y: Timed inhibition of p38MAPK directs accelerated differentiation of human embryonic stem cells into cardiomyocytes. Cytotherapy 12: 807-817, 2010.
9. Muguruma K and Sasai Y: In vitro recapitulation of neural development using embryonic stem cells: from neurogenesis to histogenesis. Dev Growth Differ 54: 349-357, 2012.
10. Samadikuchaksaraei A and Bishop AE: Derivation and characterization of alveolar epithelial cells from murine embryonic stem cells in vitro. Methods Mol Biol 330: 233-248, 2006.
11. Wang D, Haviland DL, Burns AR, Zsiqmond E and Wetsel RA: A pure population of lung alveolar epithelial type II cells derived from human embryonic stem cells. Proc Natl Acad Sci USA 104: 4449-4454, 2007. (Pubitemid 47186246)
12. Wang D, Morales JE, Calame DG, Alcorn JL and Wetsel RA: Transplantation of human embryonic stem cell-derived alveolar epithelial type II cells abrogates acute lung injury in mice. Mol Ther 18: 625-634, 2010.
13. Sugarman J: Human stem cell ethics: beyond the embryo. Cell Stem Cell 2: 529-533, 2008.
14. Tsai MS, Lee JL, Chang YJ and Hwang SM: Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol. Hum Reprod 19: 1450-1456, 2004.
15. Sessarego N, Parodi A, Podestà M, et al: Multipotent mesenchymal stromal cells from amniotic fluid: solid perspectives for clinical application. Haematologica 93: 339-346, 2008. (Pubitemid 351398634)
16. Joo S, Ko IK, Atala A, Yoo JJ and Lee SJ: Amniotic fluid-derived stem cells in regenerative medicine research. Arch Pharm Res 35: 271-280, 2012.
17. Hartmann K, Raabe O, Wenisch S and Arnhold S: Amniotic fluid derived stem cells give rise to neuron-like cells without a further differentiation potential into retina-like cells. Am J Stem Cells 2: 108-118, 2013.
18. Sun H, Feng K, Hu J, Soker S, Atala A and Ma PX: Osteogenic differentiation of human amniotic fluid-derived stem cells induced by bone morphogenetic protein-7 and enhanced by nanofibrous scaffolds. Biomaterials 31: 1133-1139, 2010.
19. Carraro G, Perin L, Sedrakyan S, et al: Human amniotic fluid stem cells can integrate and differentiate into epithelial lung lineages. Stem Cells 26: 2902-2911, 2008.
20. Perin L, Sedrakyan S, Da Sacco S and De Filippo R: Characterization of human amniotic fluid stem cells and their pluripotential capability. Methods Cell Biol 86: 85-99, 2008.
21. De Coppi P, Bartsch G Jr, Siddiqui MM, et al: Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 25: 100-106, 2007. (Pubitemid 46087908)
22. Roubelakis MG, Trohatou O and Anagnou NP: Amniotic fluid and amniotic membrane stem cells: marker discovery. Stem Cells Int 2012: 107836, 2012.
23. Benavides OM, Petsche JJ, Moise KJ Jr, Johnson A and Jacot JG: Evaluation of endothelial cells differentiated from amniotic fluid-derived stem cells. Tissue Eng Part A 18: 1123-1131, 2012.
24. Tondeur S, Assou S, Nadal L, Hamamah S and De Vos J: Biology and potential of human embryonic stem cells. Ann Biol Clin (Paris) 66: 241-247, 2008 (In French). (Pubitemid 351954837)
25. Sisson TH, Mendez M, Choi K, et al: Targeted injury of type II alveolar epithelial cells induces pulmonary fibrosis. Am J Respir Crit Care Med 181: 254-263, 2010.
26. Kuwano K: Epithelial cell apoptosis and lung remodeling. Cell Mol Immunol 4: 419-429, 2007.
27. Zhao CZ, Fang XC, Wang D, Tang FD and Wang XD: Involvement of type II pneumocytes in the pathogenesis of chronic obstructive pulmonary disease. Respir Med 104: 1391-1395, 2010.
28. Antonucci I, Pantalone A, Tete S, Salini V, Borlongan CV, Hess D and Stuppia L: Amniotic fluid stem cells: a promising therapeutic resource for cell-based regenerative therapy. Curr Pharm Des 18: 1846-1863, 2012.
29. Rippon HJ, Polak JM, Qin M and Bishop AE: Derivation of distal lung epithelial progenitors from murine embryonic stem cells using a novel three-step differentiation protocol. Stem Cells 24: 1389-1398, 2006. (Pubitemid 44464707)
30. Kubo A, Shinozaki K, Shannon JM, et al: Development of definitive endoderm from embryonic stem cells in culture. Development 131: 1651-1662, 2004. (Pubitemid 38559291)
31. Massagué J and Gomis RR: The logic of TGFbeta signaling. FEBS Lett 580: 2811-2820, 2006.
32. Cao Y, Siegel D and Knöchel W: Xenopus POU factors of subclass V inhibit activin/nodal signaling during gastrulation. Mech Dev 123: 614-625, 2006. (Pubitemid 44293379)
33. Hansson M, Olesen DR, Peterslund JM, et al: A late requirement for Wnt and FGF signaling during activin-induced formation of foregut endoderm from mouse embryonic stem cells. Dev Biol 330: 286-304, 2009.